Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1/2 11Phase 1 9Phase NA 2Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 47Squamous Cell Carcinoma of Head and Neck 30Head and Neck Neoplasms 17Colonic Neoplasms 15Rectal Neoplasms 12Parkinson Disease 4, Autosomal Dominant Lewy Body 7Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Squamous Cell 4Recurrence 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Carcinoma 3Oropharyngeal Neoplasms 2Mouth Neoplasms 2Lung Neoplasms 2Laryngeal Diseases 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Tongue Neoplasms 1Stomach Neoplasms 1Rectal Diseases 1Radiation Injuries 1Precancerous Conditions 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Follicular 1Intestinal Neoplasms 1

Interventions

Gemcitabine 74Fluorouracil 31Oxaliplatin 21Leucovorin 21130-nm albumin-bound paclitaxel 17Capecitabine 14Irinotecan 12Albumin-Bound Paclitaxel 10irinotecan sucrosofate 8Radiotherapy 6Taxes 5Erlotinib Hydrochloride 5folfirinox 4rubitecan 3Surgical Procedures, Operative 3Specimen Handling 3Pancreaticojejunostomy 3Neoadjuvant Therapy 3Drug Therapy 3Cisplatin 3Chemotherapy, Adjuvant 3ruxolitinib 2masitinib 2dehydroftorafur 2Saline Solution 2S 1 (combination) 2Paclitaxel 2GV1001 peptide 2Fentanyl 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Pancreatic Neoplasms × Cetuximab × Clear all
NCT00075686 2015-11-17

S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

SWOG Cancer Research Network

Phase 3 Completed
766 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡